Jacob Van Naarden Eli Lilly & CO (LLY) insider trading activity
Jacob Van Naarden is EVP & Pres., Lilly Oncology of ELI LILLY & Co. Currently has a direct ownership of 11,845 shares of LLY, which is worth approximately $9.42 Million. The most recent transaction as insider was on Oct 31, 2024, when has been sold 4,302 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
11.8K
26.64%
3M change
0%
12M change
Total Value Held
$9.42 Million
Jacob Van Naarden Transaction History
JVN
Jacob Van Naarden
EVP & Pres., Lilly Oncology
Indianapolis, IN